Valsartan
Valsartan is a premium-grade, white to off-white fine crystalline powder tetrazole-derivative active pharmaceutical ingredient carrying CAS number 137862-53-4. Processed under strict GMP quality compliance, this high-purity therapeutic substance exhibits exceptional receptor-binding affinity parameters and reliable molecular matrix configuration, making it an ideal core choice for manufacturing industrial anti-hypertensive solid dosages, advanced cardiovascular combination formulations, and modern clinical research assays globally.
Description
Zyntex supplies high-purity Valsartan (CAS 137862-53-4) tailored specifically for global pharmaceutical manufacturing plants, cardiology research laboratories, and international medicine synthesis loops.
Functioning as a highly specific non-peptide angiotensin II receptor antagonist and vasküler smooth muscle regulator, it delivers precise substance profiles that ensure uniform dry batch integration and highly predictable dissolution kinetics in solid dosage vehicles. Furthermore, its strictly minimized chiral impurities and controlled polymorphic structure make it an ideal selection for sensitive tablet compression profiles and continuous wet granulation industrial lines. Accordingly, formulation scientists specify this active substance to stabilize modern tetrazole carriers and maintain exact potency integrity across continuous processing cycles.
Angiotensin AT1 Blockade Efficiency and Solid Matrix Homogeneity
Excellent crystalline thermodynamic performance and outstanding excipient binding affinity provide a distinct operational edge when engineering modern fast-acting cardiac formulations. This active pharmaceutical solid operates by selectively binding to the AT1 receptor subtype to block downstream vasoconstrictor path routines, supplying the exact chemical mechanisms required to modulate arterial contraction forces without altering raw mass uniformity. It assists compounding engineers in maintaining strict active concentration uniformity across high-speed twin-screw blenders and automated rotary tablet presses, mitigating trace batch segregation risks within complex microcrystalline cellulose matrices. For instance, specialized pharmaceutical facilities incorporate this refined organic compound powder as a core active component in targeted fixed-dose combination anti-hypertensive batches. As a consequence, it maximizes the technical throughput of automated high-shear granulator machinery and continuous quality assurance checks. Consequently, Zyntex coordinates clean room crystallization paths to eliminate downstream solvate-induced physical breakdown from your factory schedule.
In addition to this, Zyntex coordinates climate-controlled logistics for pilot-scale manufacturing operations and advanced cardiovascular drug development centers. The compound maintains its refined chemical structure integrity under strict humidity parameters, preventing moisture-driven polymorphic conversion or thermal chemical degradation during automated mechanical blending steps. It advances contemporary medical engineering by providing a thoroughly analyzed, highly predictable non-peptide raw material that meets international pharmacopoeia monograph standards. Simultaneously, it remains a critical chemical standard for routine high-performance liquid chromatography (HPLC) active ingredient assays and dissolution profile validation loops. In brief, our product functions as a dependable chemical foundation, supporting both the performance of commercial clinical batches and the analytical rigor of specialized industrial laboratories.
Primary Medical Sectors for Valsartan
This high-purity crystalline active drug compound delivers crucial technical value within these four primary industrial sectors:
%E2%9A%93 Anti-Hypertensive Monotablets
Primary therapeutic active source used for formulating standalone 40mg, 80mg, and 160mg high-yield prescription coatings. Hence, it directly supports optimal release control lines.
%E2%9A%AC Fixed-Dose Combinations
Utilized as a high-purity active base to compound multi-component tablets blending calcium channel blockers or diuretics into single matrices. Clearly, it is key for uniform dissolving patterns.
%E2%9C%92 Heart Failure Therapeutics
Acts as an essential reference standard for compounding modern neprilysin inhibitor dual-acting crystalline complex structures. Resultantly, it guarantees excellent matrix clarity.
%E2%93%A2 Pharmacopoeia Assay Loops
Used as a professional high-purity component for validating advanced structural elution kinetics and tracking trace nitrosamine filtration steps. Specifically, it confirms optimal reaction pathways.
Technical Specifications
| Parameter | Standard Value |
|---|---|
| Product Name | Valsartan (Tetrazole-Derivative API) |
| Standard Grade | USP / EP / BP Quality Compliance (GMP Pharma Grade) |
| Assay / Purity (HPLC) | 98.0% to 102.0% (calculated on anhydrous basis) |
| Appearance | White to off-white fine crystalline powder |
| Heavy Metals | Max 10 ppm |
| CAS Number | 137862-53-4 |
%E2%9A%A0 Safety & Handling (STRONG PHARMACOLOGICAL ACTIVE / FETOTOXIC RISK): Valsartan is a highly stable, non-hazardous organic compound displaying predictable physical properties. However, accidental oral ingestion or direct inhalation of pure industrial API powder triggers aggressive systemik hypotension, sudden dizzying syncope, gastrointestinal imbalance, and serious fetotoxic embryonic developmental hazards if handled during pregnancy phases. Therefore, store strictly inside original, light-shielded, double-lined polyethylene airtight drum setups within a dry, exceptionally cool, and strictly monitored controlled-access farmasötik raw material depot facility totally isolated from open atmospheric moisture, high heat, and oxidizing chemicals. Keep container lids locked when not actively weighing components to minimize cross-contamination. Mandatory personal safety arrangements—including pharmaceutical-grade nitrile gloves, dust-proof medical safety goggles, protective lab coveralls, and an approved HEPA particulate air respirator mask—must be systematically maintained during all processing shifts. Review the Safety Data Sheet (SDS).
